| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.071 | 0.7 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.064 | 0.7 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |